I-Tolvaptan CAS 150683-30-0 API Purity >99.0% (HPLC)

Incazelo emfushane:

Igama Lekhemikhali: Tolvaptan

I-CAS: 150683-30-0

Ukuhlanzeka (HPLC): >99.0%

Ukubukeka: I-Crystalline Powder Emhlophe ukuya Kokumhlophe

Isitha esinamandla nesikhethayo se-vasopressin V2 receptor

Ikhwalithi ephezulu ye-API, Ukukhiqiza Kwezentengiso

Inquiry: alvin@ruifuchem.com  


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Chemical Properties:

Igama I-Tolvaptan
Igama Lekhemikhali N- [4-(9-chloro-6-hydroxy-2-azabicyclo[5.4.0]undeca-8,10,12-triene-2-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide
Inombolo ye-CAS 150683-30-0
Inombolo yeCAT I-RF-API101
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula I-C26H25ClN2O3
Isisindo samangqamuzana 448.94
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka I-Crystalline Powder emhlophe ukuya kokumhlophe
Izindlela Zokuhlonza IR, HPLC
Ukuncibilika Incibilika ku-Benzyl Alcohol ne-Methanol kodwa Ayincibiliki Emanzini ne-Hexane
Ukuhlanzeka / Indlela Yokuhlaziya >99.0% (HPLC)
I-Melting Point 219.0~222.0℃
Ukulahlekelwa Ekumisweni <0.50%
Izinsalela ekushiseni <0.10%
Ukungcola Okukodwa <0.50%
Ukungcola Okuphelele <1.00%
Izinsimbi Ezisindayo ≤20ppm
Izincibilikisi Ezisele Hlangana nencazelo
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-API;Pharmaceutical Intermediates

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

1

I-FAQ:

Isicelo:

I-Tolvaptan (CAS: 150683-30-0), eyaziwa nangokuthi i-OPC-41061, iyisitha esikhethiwe, esincintisana ne-arginine vasopressin receptor 2 esetshenziselwa ukwelapha i-hyponatremia (amazinga aphansi e-sodium yegazi) ahlotshaniswa nokuhluleka kwenhliziyo, i-cirrhosis, kanye nesifo se-syndrome. i-hormone ye-antidiuretic engalungile (SIADH).I-Otsuka Pharmaceutical enelayisensi ye-tolvaptan ngaphansi kwegama lokuhweba i-Samsca ngemuva kokuthi i-FDA igunyaze umuthi ngoMeyi 2009. I-Tolvaptan iphinde yabonisa ukusebenza ngempumelelo ekulweni nesifo sezinso se-polycystic.Ocwaningweni lwango-2004, i-tolvaptan esetshenziswa nge-diuretics yendabuko yaphawuleka ukuthi inyusa ukuphuma koketshezi oluningi futhi ithuthukise amazinga e-sodium egazini ezigulini ezinokwehluleka kwenhliziyo ngaphandle kokukhiqiza imiphumela emibi efana ne-hypotension (umfutho wegazi ophansi) noma i-hypokalemia (ukwehla kwamazinga e-potassium egazi).Umuthi futhi awuzange ubonise umthelela omubi ekusebenzeni kwezinso.

Bhala umyalezo wakho lapha futhi usithumelele wona